Enhanced heart disease risk prediction using adaptive botox optimization based deep long-term recurrent convolutional network.
Abstract
[BACKGROUND] Heart disease is the leading cause of death worldwide and predicting it is a complex task requiring extensive expertise. Recent advancements in IoT-based illness prediction have enabled accurate classification using sensor data.
[OBJECTIVE] This research introduces a methodology for heart disease classification, integrating advanced data preprocessing, feature selection, and deep learning (DL) techniques tailored for IoT sensor data.
[METHODS] The work employs Clustering-based Data Imputation and Normalization (CDIN) and Robust Mahalanobis Distance-based Outlier Detection (RMDBOD) for preprocessing, ensuring data quality. Feature selection is achieved using the Improved Binary Quantum-based Avian Navigation Optimization (IBQANO) algorithm, and classification is performed with the Deep Long-Term Recurrent Convolutional Network (DLRCN), fine-tuned using the Adaptive Botox Optimization Algorithm (ABOA).
[RESULTS] The proposed models tested on the Hungarian, UCI, and Cleveland heart disease datasets demonstrate significant improvements over existing methods. Specifically, the Cleveland dataset model achieves an accuracy of 99.72%, while the UCI dataset model achieves an accuracy of 99.41%.
[CONCLUSION] This methodology represents a significant advancement in remote healthcare monitoring, crucial for managing conditions like high blood pressure, especially in older adults, offering a reliable and accurate solution for heart disease prediction.
[OBJECTIVE] This research introduces a methodology for heart disease classification, integrating advanced data preprocessing, feature selection, and deep learning (DL) techniques tailored for IoT sensor data.
[METHODS] The work employs Clustering-based Data Imputation and Normalization (CDIN) and Robust Mahalanobis Distance-based Outlier Detection (RMDBOD) for preprocessing, ensuring data quality. Feature selection is achieved using the Improved Binary Quantum-based Avian Navigation Optimization (IBQANO) algorithm, and classification is performed with the Deep Long-Term Recurrent Convolutional Network (DLRCN), fine-tuned using the Adaptive Botox Optimization Algorithm (ABOA).
[RESULTS] The proposed models tested on the Hungarian, UCI, and Cleveland heart disease datasets demonstrate significant improvements over existing methods. Specifically, the Cleveland dataset model achieves an accuracy of 99.72%, while the UCI dataset model achieves an accuracy of 99.41%.
[CONCLUSION] This methodology represents a significant advancement in remote healthcare monitoring, crucial for managing conditions like high blood pressure, especially in older adults, offering a reliable and accurate solution for heart disease prediction.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botox
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | heart
|
scispacy | 1 | ||
| 해부 | blood
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Heart disease
|
scispacy | 1 | ||
| 약물 | CDIN
→ Clustering-based Data Imputation and Normalization
|
scispacy | 1 | ||
| 질환 | heart disease
|
C0018799
Heart Diseases
|
scispacy | 1 | |
| 질환 | death
|
C0011065
Cessation of life
|
scispacy | 1 | |
| 질환 | DLRCN
→ Deep Long-Term Recurrent Convolutional Network
|
scispacy | 1 |
MeSH Terms
Humans; Deep Learning; Algorithms; Heart Diseases; Neural Networks, Computer; Risk Assessment; Internet of Things
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.